# First Milestone Achieved — Thank You for Helping Carry the Mission Forward | Sen-Jam Pharmaceutical

- Canonical URL: https://wefunder.com/feed/351231
- Entity ID: wefunder:feed_item:351231
- Published at: 2026-07-12 14:55:42 UTC
- Updated at: 2026-07-14 02:31:57 UTC

## Author
Jim Iversen

## Subject
Sen-Jam Pharmaceutical

## Content
Dear Sen-Jam Community,We are grateful to share that Sen-Jam has reached the first milestone in our current Reg D 506(b) bridge round: $250,000 raised.Thank you to everyone who has already stepped forward to support this next stage of the journey. Your belief, encouragement, and continued investment mean more than capital alone. They are a reminder that this mission is being carried by a community of people who understand the importance of the work we are doing.At Sen-Jam, we have built more than a pipeline. We have built a belief:Resolution is critical to helping people live longer, healthier, more resilient lives.That belief guides our science, our platform, our partnerships, our investor conversations, and the evolution of Galaxy.Our proof continues to build through clinical work, biomarker insights, intellectual property, regulatory progress, and the repeated signal that inflammation resolution may represent a powerful path forward across multiple areas of human health.Our plan continues to sharpen through Galaxy — our expanding architecture for discovering, developing, connecting, funding, and executing inflammation-resolution therapeutics at scale. Atlas continues to evolve as our discovery engine. Constellation is helping us think more broadly about strategic pathways and partnerships. Sextant is being designed to protect flow by turning operational complexity into structured execution.Our people continue to grow stronger. We are surrounded by aligned investors, partners, collaborators, institutions, advisors, and team members who are helping us move the mission forward with conviction and stewardship. Reaching this first milestone matters. It strengthens our bridge to the next stage and gives us an opportunity to continue inviting aligned capital into the work. With your continued support we expect our first Atlas discovered therapeutic candidates in September.With the $250,000 milestone achieved, the current accelerator is now +12.5% bonus shares, available until the next milestone is reached, in addition to base perks of up to 5% based on investment size.For those who are eligible and interested in participating further, this is an opportunity to help advance Sen-Jam as our proof builds, Galaxy evolves, and the bigger stage begins to open.Thank you for being on this journey with us.Please take a moment to find joy and gratitude in what we are building together:→ Our Investor Deck — The physical assets, clinical programs, intellectual property, partnerships, and capabilities that make up our foundation→ Galaxy — Our computational drug discovery and development platform→ Schedule a call with me: calendly.com/jiversen→ You can view the private offering using this Wefunder linkWe believe the work ahead matters deeply — for patients, for families, for healthcare, and for the future of human resilience.With gratitude,Jim